Arvinas (ARVN) Prepaid Assets (2017 - 2026)
Arvinas' (ARVN) quarterly Prepaid Assets came in at $9.4 million in Q1 2026, down 44.71% year-on-year from $17.0 million in Q1 2025, and up 5.62% quarter-over-quarter from $8.9 million in Q4 2025.
Arvinas (ARVN) Prepaid Assets (2017 - 2026) Analysis & Trends
Arvinas' Prepaid Assets history runs 10 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 44.71% year-over-year to $9.4 million in Q1 2026; TTM through Mar 2026 was $9.4 million, a 44.71% decrease from a year earlier, with the FY2025 full-year figure at $8.9 million, down 37.32% from the prior year.
- Prepaid Assets improved to $9.4 million in Q1 2026 per ARVN's latest filing, from $8.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $21.7 million in Q3 2022 and bottomed at $6.5 million in Q4 2023.
- The 5-year median for Prepaid Assets is $13.1 million (2024), against an average of $13.6 million.
- Across the five-year window, Prepaid Assets tumbled 69.63% in 2023 and jumped 118.46% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $21.4 million in 2022, then tumbled by 69.63% to $6.5 million in 2023, then surged by 118.46% to $14.2 million in 2024, then slumped by 37.32% to $8.9 million in 2025, then climbed by 5.62% to $9.4 million in 2026.
- Per Business Quant, the three latest ARVN Prepaid Assets figures stand at $9.4 million (Q1 2026), $8.9 million (Q4 2025), and $11.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.40 Mn |
| Dec 31, 2025 | 8.90 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 17.20 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 13.10 Mn |
| Jun 30, 2024 | 12.50 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 8.40 Mn |
| Jun 30, 2023 | 7.60 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Dec 31, 2022 | 21.40 Mn |
| Sep 30, 2022 | 21.70 Mn |
| Jun 30, 2022 | 20.60 Mn |
| Mar 31, 2022 | 17.40 Mn |
| Dec 31, 2021 | 19.70 Mn |
| Sep 30, 2021 | 18.54 Mn |
| Jun 30, 2021 | 15.24 Mn |